Literature DB >> 4191179

Alternate-day steroid therapy in lupus nephritis.

G L Ackerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4191179     DOI： 10.7326/0003-4819-72-4-511

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.

Authors:  F J Frey; M K Rüegsegger; B M Frey
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

2.  The treatment of lupus nephritis by methyl prednisolone pulse therapy.

Authors:  S Dosa; S A Cairns; W Lawler; N P Mallick; I N Slotki
Journal:  Postgrad Med J       Date:  1978-09       Impact factor: 2.401

Review 3.  Current treatment recommendations for lupus nephritis.

Authors:  C Ponticelli
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

Review 4.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

5.  Alternate-day prednisone therapy and human lymphocyte subpopulations.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

Review 6.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.